BACKGROUND: Griseofulvin has been the standard treatment for tinea capitis but newer
antifungal agents, particularly terbinafine, are increasingly being used because of their …

Two oral antifungal agents, griseofulvin and terbinafine, have regulatory approval in the
United States, but it is unknown whether one has superior overall efficacy. Genus‐specific …

Objective. Tinea capitis, a common pediatric infection in the United States, is caused mainly
by Trichophyton species and affects many urban children. Although the current treatment of …

Background: Griseofulvin has been used for many years in the treatment of tinea capitis.
Increase in resistance to this medication has led to a search for new therapeutic alternatives …

Objective To compare the efficacy and safety of terbinafine with griseofulvin in the treatment
of tinea capitis in Western China. Methods Children (2–14 years of age) with clinically …

During the past decade, tinea capitis has again become a major public health concern in the
United States and elsewhere. Not only is there evidence of increasing incidence of the …

Background Tinea capitis is a common childhood infection that has recently become more
frequent in urban areas in Europe and the USA The current licensed treatment in children is …

BACKGROUND: Although griseofulvin is currently considered the primary antifungal agent
used to treat tinea capitis in many countries, increasingly higher doses and longer durations …

Currently, many experts consider griseofulvin to be the drug of choice for tinea capitis. Short-
term terbinafine, itraconazole and fluconazole therapy have been shown to be comparable …

Tinea capitis (TC) is a common childhood fungal infection which, if untreated, can cause
long‐term scarring. A number of antifungal drugs with proven efficacy are available for the …